GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
277 hedge funds and large institutions have $2.28B invested in GW Pharmaceuticals Plc American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 74 funds opening new positions, 79 increasing their positions, 71 reducing their positions, and 67 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
11% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 71
10% more first-time investments, than exits
New positions opened: 74 | Existing positions closed: 67
2% more funds holding
Funds holding: 272 → 277 (+5)
9% more call options, than puts
Call options by funds: $101M | Put options by funds: $92.9M
35% less capital invested
Capital invested by funds: $3.54B → $2.28B (-$1.25B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$118M |
| 2 |
Barclays
London,
United Kingdom
|
+$56.4M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$44.5M |
| 4 |
FAM
Fred Alger Management
New York
|
+$42.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$30.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$57M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$32.7M |
| 3 |
SCM
Scopia Capital Management
New York
|
-$18.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.6M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$13.4M |
GWPH Hedge Fund Activity: Q4 2018 in Review
277 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q4 2018, worth a combined $2.28B — down 35% from $3.54B a quarter earlier.
Buyers outnumbered sellers: 74 funds opened new GWPH positions and 67 closed out — a net gain of 7 holders — while 79 added to existing stakes and 71 trimmed.
The largest buyer was Canada Pension Plan Investment Board, adding an estimated $118M. The largest seller was Citadel Advisors, cutting an estimated $57M.
- 277 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q4 2018, up from 272 in Q3 2018.
- Funds reported $2.28B of GW Pharmaceuticals Plc American Depositary Shares stock for Q4 2018, down 35% quarter-over-quarter.
- 74 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q4 2018 and 67 closed out, a net change of +7 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q4 2018 was Canada Pension Plan Investment Board, an estimated $118M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q4 2018 was Citadel Advisors, an estimated $57M sold.
Based on aggregated 13F filings for Q4 2018.